RCSI University of Medicine and Health Sciences, 123 St. Stephen's Green, Dublin 2, Ireland.
Department of Paediatric Nephrology and Transplantation, Children's Health Ireland, Dublin, Ireland.
Pediatr Nephrol. 2024 Nov;39(11):3205-3208. doi: 10.1007/s00467-024-06408-3. Epub 2024 May 23.
Alport syndrome is a genetically heterogenous disorder resulting from variants in genes coding for alpha-3/4/5 chains of Collagen IV, which results in defective basement membranes in the kidney, cochlea and eye. The syndrome has different inheritance patterns and historically, was thought of as a disease affecting solely males.
A 15-year-old female presented with pedal oedema, hypertension and proteinuria. She underwent a kidney biopsy which showed findings in keeping with focal segmental glomerulosclerosis. Her condition was refractory to steroids. Steroid-resistant nephrotic syndrome genetics were sent, revealing a rare pathogenic variant in the COL4A5 gene.
Heterozygous females with X-linked Alport syndrome can develop chronic kidney disease and hearing loss. Clinicians should be mindful when reviewing kidney histology to include Alport syndrome as a differential for female patients. COL4A3-5 genes should be included in all steroid-resistant nephrotic syndrome genetic panels.
Alport 综合征是一种遗传性异质性疾病,由编码胶原 IV α-3/4/5 链的基因突变引起,导致肾脏、耳蜗和眼睛的基底膜缺陷。该综合征具有不同的遗传模式,历史上被认为是一种仅影响男性的疾病。
一名 15 岁女性因足踝水肿、高血压和蛋白尿就诊。她接受了肾脏活检,结果显示符合局灶节段性肾小球硬化的表现。她的病情对类固醇治疗无反应。进行了类固醇耐药性肾病综合征基因检测,发现 COL4A5 基因中有一个罕见的致病性变异。
X 连锁 Alport 综合征的杂合女性可发展为慢性肾脏病和听力损失。临床医生在审查肾脏组织学结果时应注意将 Alport 综合征作为女性患者的鉴别诊断。COL4A3-5 基因应包含在所有类固醇耐药性肾病综合征基因检测面板中。